MRI Systems Market

There is an increasing trend where a significant portion of the population is experiencing chronic back or neck pain and musculoskeletal disorders (MSDs) due to a lack of physical activity and an unhealthy lifestyle. This has led to a rise in the prevalence of conditions such as back pain, osteoarthritis, rheumatoid arthritis, and spondylarthritis. MRI is considered the gold standard for imaging soft tissues, nerves, and the spine, making it essential for diagnosing conditions like multiple sclerosis, spinal injuries, and chronic pain syndromes. The growing elderly population, projected to reach nearly 80 million by 2050, will increase the number of patients suffering from neurodegenerative diseases (such as Alzheimer’s and Parkinson’s) and musculoskeletal disorders (like spine degeneration). These conditions require frequent non-invasive diagnostic imaging procedures for proper treatment and diagnosis. As a result, the demand for MRI scans per patient is expected to rise, contributing to the growth of the MRI systems market. Globally, the risk of developing diseases continues to increase. According to the American Medical Association, nearly 60% of individuals aged 65 and older in the U.S. are expected to live with more than one chronic condition. With the rapid growth of the baby boomer population, the prevalence of age-related complications and diseases such as cardiovascular diseases, Alzheimer’s disease, and cancer is consistently rising. These factors are also anticipated to drive up the demand for MRI systems.

Helium is an inert gas, meaning it is non-reactive in its natural state. It has the lowest boiling point of any element, at -269 °C (-452 °F), and a low density. Various industrial applications utilize helium to cool instruments and maintain optimal operating conditions. According to a BBC report from 2025, hospitals are the largest consumers of helium worldwide, accounting for approximately 32% of the global market. Helium is essential for cooling the magnets in diagnostic tools like magnetic resonance imaging (MRI) systems. The most recent helium shortage was noted in 2024, which intensified the demand for this gas. Expanding manufacturing capabilities in the semiconductor and battery industries have created new channels for helium demand and usage, highlighting its scarcity. A helium facility in Qatar was temporarily offline for scheduled maintenance, and the ongoing conflict in Ukraine exacerbated supply issues. Additionally, rising tensions in the Middle East may disrupt the helium supply chain, particularly impacting the MRI ecosystem, as a significant portion of the world's helium supply comes from Qatar and nearby Gulf countries. Reports from March to April 2026 indicated that conflict-related disruptions had significantly reduced global helium availability, resulting in sharp price increases. Since helium is used to cool superconducting magnets in conventional MRI systems, higher prices and limited availability could lead to increased operating costs, delays in maintenance, and higher expenses for new MRI deployments at hospitals and diagnostic centers.

As more hospitals and diagnostic centers develop child-friendly services, there is a growing demand for MRI systems, pediatric coils, faster protocols, and comfort-focused features. This demand directly supports equipment sales and service revenue. Pediatric MRI is largely driven by the increasing prevalence of neurological disorders, congenital anomalies, cancer, and other conditions that require early and precise imaging in children. Children often require shorter scan times, reduced noise levels, and an improved patient experience. As a result, providers cannot always rely on a generic MRI workflow. This need for specialized systems or upgrades prompts institutions to make new investments. Consequently, there is an emerging cycle of replacement and expansion for vendors serving hospitals, diagnostic centers, and specialty clinics.

Limited capital budgets among healthcare providers, such as hospitals and diagnostic imaging centers—especially in tier 2 and tier 3 cities, as well as community hospitals and outpatient centers—have resulted in the extended use of MRI systems beyond their recommended operational warranties. The American College of Radiology recommends upgrading MRI equipment every 7 to 10 years; however, real-world usage often extends to 12 to 15 years due to financial constraints. According to a 2023 report by GE Healthcare, nearly 60% of mid-sized radiology departments in the U.S. have delayed MRI upgrades after the pandemic, focusing on financial recovery rather than capital expenditure. Consequently, many aging MRI systems with lower signal-to-noise ratios and slower scan speeds continue to be used, which can compromise image quality and diagnostic accuracy—especially in complex neurological or oncological cases. Additionally, legacy systems frequently lack compatibility with modern imaging advancements, such as AI-based reconstruction, compressed sensing, and advanced coil technologies. Original Equipment Manufacturers (OEMs) like Siemens and Philips have noted that these limitations can reduce the clinical value of imaging, increase the rate of false negatives, and limit throughput.